Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 1
2008 3
2009 1
2010 2
2011 6
2012 2
2013 4
2014 7
2015 11
2016 9
2017 9
2018 10
2019 17
2020 15
2021 7
2022 4
2023 1
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 36634942

100 results
Results by year
Filters applied: . Clear all
Page 1
[Clinical features and outcomes of newly diagnosed follicular lymphoma concurrent with diffuse large B-cell lymphoma component].
Lin ZJ, Zha J, Yi SH, Li ZF, Ping LY, He XH, Yu HF, Zheng Z, Xu W, Chen FL, Xie Y, Chen BY, Zhang HL, Wang L, Ding KY, Li WY, Yang HY, Zhao WL, Qiu LG, Li ZM, Song YQ, Xu B. Lin ZJ, et al. Zhonghua Xue Ye Xue Za Zhi. 2022 Jun 14;43(6):456-462. doi: 10.3760/cma.j.issn.0253-2727.2022.06.003. Zhonghua Xue Ye Xue Za Zhi. 2022. PMID: 35968587 Free PMC article. Chinese.
Clinicopathological analysis of primary refractory diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone chemoimmunotherapy.
Suzuki T, Maruyama D, Miyagi-Maeshima A, Nomoto J, Tajima K, Ito Y, Hatta S, Yuda S, Makita S, Fukuhara S, Munakata W, Suzuki T, Taniguchi H, Izutsu K, Kobayashi Y, Tobinai K. Suzuki T, et al. Cancer Med. 2021 Aug;10(15):5101-5109. doi: 10.1002/cam4.4062. Epub 2021 Jun 9. Cancer Med. 2021. PMID: 34105893 Free PMC article.
Peripheral Blood Lymphocyte-to-Monocyte Ratio at Relapse Predicts Outcome for Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma in the Rituximab Era.
Katoh D, Ochi Y, Yabushita T, Ono Y, Hiramoto N, Yoshioka S, Yonetani N, Matsushita A, Hashimoto H, Kaji S, Imai Y, Ishikawa T. Katoh D, et al. Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):e91-e97. doi: 10.1016/j.clml.2017.08.096. Epub 2017 Aug 14. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28918104
100 results